BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21402696)

  • 1. Unique interaction pattern for a functionally biased ghrelin receptor agonist.
    Sivertsen B; Lang M; Frimurer TM; Holliday ND; Bach A; Els S; Engelstoft MS; Petersen PS; Madsen AN; Schwartz TW; Beck-Sickinger AG; Holst B
    J Biol Chem; 2011 Jun; 286(23):20845-60. PubMed ID: 21402696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the constitutive activity of the ghrelin receptor by use of pharmacological tools and mutagenesis.
    Mokrosiński J; Holst B
    Methods Enzymol; 2010; 484():53-73. PubMed ID: 21036226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
    Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
    Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.
    M'Kadmi C; Leyris JP; Onfroy L; Galés C; Saulière A; Gagne D; Damian M; Mary S; Maingot M; Denoyelle S; Verdié P; Fehrentz JA; Martinez J; Banères JL; Marie J
    J Biol Chem; 2015 Nov; 290(45):27021-27039. PubMed ID: 26363071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism.
    Holst B; Mokrosinski J; Lang M; Brandt E; Nygaard R; Frimurer TM; Beck-Sickinger AG; Schwartz TW
    J Biol Chem; 2007 May; 282(21):15799-811. PubMed ID: 17371869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common structural basis for constitutive activity of the ghrelin receptor family.
    Holst B; Holliday ND; Bach A; Elling CE; Cox HM; Schwartz TW
    J Biol Chem; 2004 Dec; 279(51):53806-17. PubMed ID: 15383539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An aromatic region to induce a switch between agonism and inverse agonism at the ghrelin receptor.
    Els S; Schild E; Petersen PS; Kilian TM; Mokrosinski J; Frimurer TM; Chollet C; Schwartz TW; Holst B; Beck-Sickinger AG
    J Med Chem; 2012 Sep; 55(17):7437-49. PubMed ID: 22920150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors.
    Holst B; Nygaard R; Valentin-Hansen L; Bach A; Engelstoft MS; Petersen PS; Frimurer TM; Schwartz TW
    J Biol Chem; 2010 Feb; 285(6):3973-3985. PubMed ID: 19920139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G Protein and β-arrestin signaling bias at the ghrelin receptor.
    Evron T; Peterson SM; Urs NM; Bai Y; Rochelle LK; Caron MG; Barak LS
    J Biol Chem; 2014 Nov; 289(48):33442-55. PubMed ID: 25261469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biased Gs versus Gq proteins and β-arrestin signaling in the NK1 receptor determined by interactions in the water hydrogen bond network.
    Valentin-Hansen L; Frimurer TM; Mokrosinski J; Holliday ND; Schwartz TW
    J Biol Chem; 2015 Oct; 290(40):24495-508. PubMed ID: 26269596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor.
    Holst B; Frimurer TM; Mokrosinski J; Halkjaer T; Cullberg KB; Underwood CR; Schwartz TW
    Mol Pharmacol; 2009 Jan; 75(1):44-59. PubMed ID: 18923064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues.
    Liao Y; Lu B; Ma Q; Wu G; Lai X; Zang J; Shi Y; Liu D; Han F; Zhou N
    J Biol Chem; 2016 Apr; 291(14):7505-16. PubMed ID: 26865629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G12/13 is activated by acute tethered agonist exposure in the adhesion GPCR ADGRL3.
    Mathiasen S; Palmisano T; Perry NA; Stoveken HM; Vizurraga A; McEwen DP; Okashah N; Langenhan T; Inoue A; Lambert NA; Tall GG; Javitch JA
    Nat Chem Biol; 2020 Dec; 16(12):1343-1350. PubMed ID: 32778842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias.
    Bolognini D; Moss CE; Nilsson K; Petersson AU; Donnelly I; Sergeev E; König GM; Kostenis E; Kurowska-Stolarska M; Miller A; Dekker N; Tobin AB; Milligan G
    J Biol Chem; 2016 Sep; 291(36):18915-31. PubMed ID: 27385588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminus of a hexapeptidic ghrelin receptor inverse agonist can switch peptide behavior from inverse agonism to agonism.
    Els-Heindl S; Bellmann-Sickert K; Beck-Sickinger AG
    Biopolymers; 2016 Jan; 106(1):101-8. PubMed ID: 26566778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
    Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
    J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased agonism of the calcium-sensing receptor.
    Thomsen AR; Hvidtfeldt M; Bräuner-Osborne H
    Cell Calcium; 2012 Feb; 51(2):107-16. PubMed ID: 22192592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists.
    Ramirez VT; van Oeffelen WEPA; Torres-Fuentes C; Chruścicka B; Druelle C; Golubeva AV; van de Wouw M; Dinan TG; Cryan JF; Schellekens H
    FASEB J; 2019 Jan; 33(1):518-531. PubMed ID: 30020830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [D-Arg(1),D-Trp(5,7,9),Leu(11)]Substance P inhibits bombesin-induced mitogenic signal transduction mediated by both G(q) and G(12) in Swiss 3T3cells.
    Sinnett-Smith J; Santiskulvong C; Duque J; Rozengurt E
    J Biol Chem; 2000 Sep; 275(39):30644-52. PubMed ID: 10880515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protease-activated receptor-2-specific agonists 2-aminothiazol-4-yl-LIGRL-NH2 and 6-aminonicotinyl-LIGRL-NH2 stimulate multiple signaling pathways to induce physiological responses in vitro and in vivo.
    Flynn AN; Tillu DV; Asiedu MN; Hoffman J; Vagner J; Price TJ; Boitano S
    J Biol Chem; 2011 May; 286(21):19076-88. PubMed ID: 21467041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.